References

1. 1.
   ZHAO X K，WANG X Q，JIANG H G，et al.Research status of effective active components of Astragalus in preventing and treating myocardial fibrosis［J］.Chin J Clin Pharmacol，2023，39（4）：593-597.
2. 2.
   FAN L H，WANG Z G，YANG X，et al.Study on interventional effect of Gelian Tiaotang pill on renal fibrosis in type 2 diabetes db/db mice through NLRP3/Caspase-1/GSDMD pathway［J］.Chin J Exp Tradit Med Form，2025，31（6）：136-145.
3. 3.
   WANG X Y，LIU H F，LIU X Z.Research progress on the mechanism of traditional Chinese medicine promoting Angiogenesis after ischemic stroke based on the PI3K/Akt signaling pathway［J］.Chin J Exp Tradit Med Form，2025，31（7）：265-274.
4. 4.
   BELLI C，REPETTO M，ANAND S，et al.The emerging role of PI3K inhibitors for solid tumour treatment and beyond［J］.Br J Cancer，2023，128 （12）：2150-2162.
5. 5.
   LEANDRO-GARCÍA L J，LANDA I.Mechanistic insights of thyroid cancer progression［J］.Endocrinology，2023，164 （9）：bqad118.
6. 6.
   WANG M，ZHANG Y L，ZOU J，et al.To investigate the effect of electroacupuncture "Jiaji point" on autophagy and apoptosis of nucleus pulposus cells in degenerative intervertebral disc based on PI3K/Akt/mTOR pathway［J/OL］.Acupunct Res，2024，.
7. 7.
   XU F，NA L，LI Y，et al.Roles of the PI3K/Akt/mTOR signalling pathways in neurodegenerative diseases and tumours［J］.Cell Biosci，2020，10（1）：54.
8. 8.
   CASTRO-CRUZ A，ECHEVERRÍA O M，SÁNCHEZ-SÁNCHEZ L，et al.Dissection of the autophagic route in oocytes from atretic follicles［J］.Biol Cell，2023，115 （3）：e2200046.
9. 9.
   CHEN J M，LIN Z L，CHEN F S，et al.Effects of PPⅥ on apoptosis and autophagy of esophageal cancer cells ECA-109 by regulating PI3K/Akt/mTOR pathway［J］.Heilongjiang Med J，2024，37（4）：767-771.
10. 10.
    ZHU Y，XU W J，ZHANG Y Y，et al.Quercetin regulates proliferation，inflammation，and oxidative stress in psoriatic keratinocytes via the NF-κB signaling pathway［J］.J Clin Pathol Res，2024，44（5）：647-655.
11. 11.
    ZHENG X，WU X，WEN Q，et al.Eriodictyol alleviated LPS/D-GalN-induced acute liver injury by inhibiting oxidative stress and cell apoptosis via PI3K/Akt signaling pathway［J］.Nutrients，2023，15 （20）：4349.
12. 12.
    DONG M，REN M，LI C，et al.Analysis of metabolic alterations related to pathogenic process of diabetic encephalopathy rats［J］.Front Cell Neurosci，2018，12：527.
13. 13.
    YE X，SHEN T，HU J，et al.Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse［J］.Exp Neurol，2017，292：46-55.
14. 14.
    CUI W.Study on the mechanism of Buyang Huanwu decoction on diabetic encephalopathy through PI3K/Akt pathway［D］.Changchun：Changchun University of Chinese Medicine，2022.
15. 15.
    WANG Z，LUO Z，TAN Y，et al.Astragaloside Ⅳ alleviates heatstroke brain injury and neuroinflammation in male mice by regulating microglial polarization via the PI3K/Akt signaling pathway［J］.Biomed Pharmacother，2024，180：117545.
16. 16.
    CHENG F，ZHANG J，YANG P，et al.Exploring the neuroprotection of the combination of astragaloside A，chlorogenic acid and scutellarin in treating chronic cerebral ischemia via network analysis and experimental validation［J］.Heliyon，2024，10 （8）：e29162.
17. 17.
    TANG X，LI X，ZHANG D，et al.Astragaloside-Ⅳ alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2［J］.Bioengineered，2022，13 （4）：8240-8254.
18. 18.
    WANG T，ZHANG Z，SONG C，et al.Astragaloside Ⅳ protects retinal pigment epithelial cells from apoptosis by upregulating miR‑128 expression in diabetic rats［J］.Int J Mol Med，2020，46 （1）：340-350.
19. 19.
    FANG Y W.The study of Mingmu Xiaomeng tablet regulates autophagythrough Pl3K/Akt/mTOR pathway in diabetic retinopathy［D］.Guangzhou：Guangzhou University of Traditional Chinese Medicine，2020
20. 20.
    YU N X，LI G Q，LI B，et al.Mechanism of Astragaloside Ⅳ in treating diabetic retinopathy based on network pharmacology and molecular docking［J］.Chin J Exp Tradit Med Form，2022，28（13）：209-216.
21. 21.
    GAO Y K，LIANG Y L，ZHU X D，et al.Advances in the research of pathogenesis and Chinese medicine role in diabetic cardiomyopathy using omics technology［J］.Chin J Integr Tradit West Med，1-5［2004-09-10］.
22. 22.
    WANG L Y，LI C，MA M Y，et al.Effects of Astragaloside Ⅳ on cardiac hypertrophy in rats with chronic heart failure based on PI3K/Akt/GSK-3β signaling pathway［J］.Chin J Clinl Pharmacol，2024，40（1）：57-61.
23. 23.
    ZHANG B，MA Q，MA F Z，et al.Astragaloside Ⅳ's therapeutic effect on myocardial infarction via affecting autophagy and the mechanism study［J］.J Sichuan Univ（Med Sci），2021，52（2）：222-228.
24. 24.
    CHENG S，ZHANG X，FENG Q，et al.Astragaloside Ⅳ exerts angiogenesis and cardioprotection after myocardial infarction via regulating PTEN/PI3K/Akt signaling pathway［J］.Life Sci，2019，227：82-93.
25. 25.
    WU Y，ZHANG H，CHEN Y H，et al.To investigate the protective mechanisms of astragaloside Ⅳ on cardiac function in diabetic cardiomyopathy rats based on the PI3K/Akt/eNOS signaling pathway［J］.Lishizhen Med Mater Med Res，2023，34（10）：2329-2332.
26. 26.
    SAKAI S，YAMAMOTO T，TAKABATAKE Y，et al.Proximal tubule autophagy differs in type 1 and 2 diabetes［J］.J Am Soc Nephrol，2019，30 （6）：929-945.
27. 27.
    YANG F，QU Q，ZHAO C，et al.Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/Akt/mTOR pathways to protect against diabetic nephropathy in mice［J］.Biomed Pharmacother，2020，129：110479.
28. 28.
    LIU C Q，HUANG S J，JIANG D.Effect of astragaloside combined with losartan on PI3K/Akt/NF-κB pathway in diabetic rat kidney［J］.Cent South Pharm，2019，17 （10）：1626-1630.
29. 29.
    SU X，GUO H，ZHOU Y，et al.Astragaloside Ⅳ attenuates high glucose-induced NF-κB-mediated inflammation through activation of PI3K/Akt-ERK-dependent Nrf2/ARE signaling pathway in glomerular mesangial cells［J］.Phytother Res，2023，37 （9）：4133-4148.
30. 30.
    SUN L，YANG Z，ZHAO W，et al.Integrated lipidomics，transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus［J］.J Ethnopharmacol，2022，283：114699.
31. 31.
    LV J，SU M，WANG Y，et al.Yunvjian decoction mitigates hyperglycemia in rats induced by a high-fat diet and streptozotocin via reducing oxidative stress in pancreatic beta cells［J］.J Ethnopharmacol，2024，327：118045.
32. 32.
    GONG P，XIAO X，WANG S，et al.Hypoglycemic effect of astragaloside Ⅳ via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/Akt pathway［J］.J Ethnopharmacol，2021，281：114558.
33. 33.
    LIN Y，XU Y，ZHENG X，et al.Astragaloside Ⅳ ameliorates streptozotocin induced pancreatic β-cell apoptosis and dysfunction through SIRT1/P53 and Akt/GSK3β/Nrf2 signaling pathways［J］.Diabetes Metab Syndr Obes，2022，15：131-140.
34. 34.
    QING J，ZHOU H，CHEN L，et al.Effect and mechanism of carvacrol on liver injury in type 2 diabetes mellitus［J］.Chin Arch Tradit Chin Med，2024，42 （02）：131-135+280-284.
35. 35.
    SONG L，LI Y，XU M.Exogenous nucleotides ameliorate insulin resistance induced by palmitic acid in HepG2 cells through the IRS-1/Akt/FOXO1 pathways［J］.Nutrients，2024，16 （12）：1801.
36. 36.
    XU Y，HUANG C D，LI Z Q，et al.Protective effects of astragaloside Ⅳ on liver injury in diabetic rats and its mechanism［J］.Acta Univ Med Anhui，2017，52 （12）：1823-1829.
37. 37.
    ZHENG W，YANG S S，LIN Y，et al.Impact of pumpkin polysaccharides on hypoxia/reoxygenation-induced myocardial cell injury by regulating Nrf2/γ-GCS pathway［J］.Chin J Immunol，2024，40（9）：1871-1875.
38. 38.
    JI T J.Molecular mechanism of astragaloside Ⅳ regulating PI3K/Akt pathway to improve abnormal liver glucose metabolism in type 2 diabetic rats［D］.Hefei：Anhui Medical University，2020.
39. 39.
    ZHU X L，LIAO W Q，ZHANG C，et al.Pathogenesis and treatment of diabetic foot ulcer［J］.Chin J Dermatovenereol，2023，37（4）：367-372.
40. 40.
    JI X R，BAI C P，LI X L，et al.Discussion on the mechanism of Chinese medicinals pair Huangqi-Guizhi on diabetic foot based on network pharmacology［J］.Clin J Chin Med，2021，13（28）：33-38.
41. 41.
    ABD EL-KHALIK S R ，HAFEZ Y M，ELKHOLY R A.The role of circulating soluble fms-like tyrosine kinase-1 in patients with diabetic foot ulcer：A possible mechanism of pathogenesis via a novel link between oxidative stress，inflammation and angiogenesis［J］.Microvasc Res，2020，130：103987.
42. 42.
    ZHANG J，ZHANG G S，HUANG X，et al.Effects of beraprost sodium tablets combined with Danggui Huangqi Decoction（当归黄芪汤）on wound healing，angiogenesis and oxidative stress in diabetic foot ulcer patients［J］.Chin Arch Tradit Chin Med，2024，42（7）：202-205.
43. 43.
    SHAO S，LU M L，WANG H X，et al.Protective effect of astragaloside Ⅳ on oxidative injury of MC3T3-E1 cells induced by liposolysaccharideand its mechanism［J］.J Jilin Univ（Med Edi），2023，49（1）：1-7.
44. 44.
    LAI P K，CHAN J Y，CHENG L，et al.Isolation of anti-inflammatory fractions and compounds from the root of Astragalus membranaceus［J］.Phytother Res，2013，27 （4）：581-587.
45. 45.
    LI X，WANG Y，TU S W，et al.Research progress on the role and mechanism of mitochondrial apoptosis in diabetic peripheral neuropathy［J］.Chin Med Mod Dist Edu China，2021，19（4）：200-204.
46. 46.
    YIN Y，QU H，YANG Q，et al.Astragaloside Ⅳ alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy［J］.Phytomedicine，2021，92：153749.
47. 47.
    WU Y T.Clinical effect of danzhi jiangtangcapsule on type 2 diabetic macroangiopathyand its effect on ASK1-JNK signal pathway inaorta of sd rat［D］.Hefei：Anhui University of Traditional Chinese Medicine，2022.
48. 48.
    PENG M J，TANG R，LUO K，et al.Pharmacological research progress of Huangqi Danggui under different combinations［J］.Sci Technol Vis，2017，（36）：17，48.
49. 49.
    WANG N，ZHANG X，MA Z，et al.Combination of tanshinone Ⅱ_A and astragaloside Ⅳ attenuate atherosclerotic plaque vulnerability in ApoE^-/- mice by activating PI3K/Akt signaling and suppressing TRL4/NF-κB signaling［J］.Biomed Pharmacother，2020，123：109729.
50. 50.
    LI S，SUN Y，HUANG J，et al.Anti-tumor effects and mechanisms of Astragalus membranaceus （AM） and its specific immunopotentiation：Status and prospect［J］.J Ethnopharmacol，2020，258：112797.
51. 51.
    LUO Y Y，MENG M H，LI Y，et al.Copper influences the occurrence and development of diabetic complications［J］.Chin J Tissue Engin Res，2025，29（17）：3641-3649.
52. 52.
    XU R S，YANG X M，XU Y F，et al.Therapeutic effect of Astragaloside Ⅳ based on phosphatidylinositol 3-kinase/protein kinase B（PI3K/Akt） signaling pathway［J］.Chin J Clin Pharmacol，2022，38（8）：855-858，873.